Skip to main content
. Author manuscript; available in PMC: 2014 Mar 16.
Published in final edited form as: J Proteome Res. 2010 Feb 5;9(2):865–875. doi: 10.1021/pr900761m

Table 3.

Association between immunosuppressant-induced changes in the expression of proteins involved in energy metabolism (A), expression of kidney aminoacylase (B) and the urine concentrations of their corresponding substrates and/or products.

Control Srl1 CsA10 CsA10
+ Srl1
Tac1 Tac1
+ Srl1
A Pre-TCA cycle
[‰ of total integral]
13 144* 169* 189* 121* 30↑
TCA cycle
[‰ of total integral]
173 100* 121↓ 64* 129↓ 114↓
Pyruvate kinase
[% of control]
100 180* 160↑ 220* 140* 160↑
NADH oxidoreductase
[% of control]
100 30* 40* 30* 110 110
B Hippurate
[‰ of total integral]
47.2 15.0* 13.1* 4.7* 23.3↓ 21.9↓
Kidney aminoacylase-1
[% of control]
100 165* 190* 195* 100 155↑
C α-glucose
[‰ of total integral]
4.0 2.3 28.9* 117.0* 4.8 2.9
F-1,6-BP
[% of control]
100 120 187* 171* 103 106
D Creatine
[‰ of total integral]
6.0 28.6* 2.5 28.9* 3.7 22.4*
AGAT
[% of control]
100 61* 122 85 103 74*

Arrows mark the direction of concentration changes.

*

significant changes p<0.05 (Tukey test pairwise comparison to controls).

Abbreviations: CsA10: 10 mg/kg/d cyclosporine, CsA10+Srl1: 10 mg/kg/d cyclosporine+ 1 mg/kg/d sirolimus, Srl1: 1 mg/kg/d sirolimus, Tac1: 1 mg/kg/d tacrolimus, Tac1+Srl1: 1 mg/kg/d tacrolimus + 1 mg/kg/d sirolimus; Pre-TCA cycle metabolites: sum of lactate and acetate concentrations; TCA cycle metabolites: sum of succinate, citrate and 2-oxoglutarate concentrations; F-1,6-BP: Fructose-1,6-bisphosphatase, AGAT: Arginine:glycine-amidinotransferase.